Excerpts from Hearings of the Subcommittee on Executive Reorganization of the Senate Committee on Government Operations concerning federal drug research and regulation of LSD

Excerpts from Hearings of the Subcommittee on Executive Reorganization of the Senate Committee on Government Operations concerning federal drug research and regulation of LSD

Contributor(s):
Goddard, James L. (James Lee), 1923-2009
Kennedy, Robert F., 1925-1968
Lee, Philip R. (Philip Randolph), 1924-
Yolles, Stanley F., 1919-2001
United States. Congress. Senate. Committee on Government Operations. Subcommittee on Executive Reorganization and Government Research
Publication:
Produced: 24 May 1966
Language(s):
English
Format:
Sound recording
Subject(s):
Lysergic Acid Diethylamide
Research -- organization & administration
Substance-Related Disorders -- prevention & control
Abstract:
Partial recording of Senate subcommittee hearings. Senator Robert F. Kennedy (D-MA) convened this subcommittee hearing to discuss government-directed and -funded research on lysergic acid diethylamide (LSD), proposed restrictions on such research, and ways in which government agencies including the Food and Drug Administration and the National Institute of Mental Health could better coordinate their oversight efforts. Witnesses include James Goddard (FDA), Philip Lee (DHEW), and Stanley Yolles (NIMH).
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)
Extent:
2 sound reels (2 hrs.)
NLM Unique ID:
101702049 (See catalog record)
OCLC no.:
981819247
Permanent Link:
http://resource.nlm.nih.gov/101702049
Note(s):
Audio may not be available.
  • Audio Track #1 of 2
  • Audio Track #2 of 2

PDF Plain Text Metadata (Dublin Core)